, Tracking Stock Market Picks
Enter Symbol:
Juno Therapeutics Inc. (JUNO) [hlAlert]

down 12.96 %

Juno Therapeutics Inc. (JUNO) rated Outperform with price target $73 by FBR Capital

Posted on: Tuesday,  Aug 18, 2015  8:25 AM ET by FBR Capital

FBR Capital rated Outperform Juno Therapeutics Inc. (NASDAQ: JUNO) on 08/18/2015, when the stock price was $42.89. Since
then, Juno Therapeutics Inc. has lost 12.96% as of 01/20/2016's recent price of $37.33.
If you would have followed this FBR Capital's recommendation on JUNO, you would have lost 12.96% of your investment in 155 days.

FBR Capital uses a highly disciplined analysis focused on intrinsic value, which we developed to critically examine the capital structure of the companies we cover, as well as their competitive positions and the growth opportunities within their industries. We apply this discipline – which helps us assess how effectively a company’s managers deploy the capital entrusted to them – not only in our published research but also when making investing and underwriting judgments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/18/2015 8:25 AM Buy
42.89 73.00
as of 8/27/2015
1 Week down  -15.12 %
1 Month down  -12.96 %
3 Months   
1 YTD down  -12.96 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy